Veuron-Brain-pAb3
Overview
Veuron-Brain-pAb3, developed by Heuron Co., is an artificial intelligence software solution designed to assist in the assessment and quantification of brain pathologies from positron emission tomography (PET) amyloid scans. The tool is primarily utilized by neurologists, radiologists, and nuclear medicine specialists in clinical imaging centers and diagnostic neurology settings to support the evaluation of neurodegenerative conditions such as dementia and Alzheimer’s disease.
The software integrates into the clinical workflow by processing DICOM and NIfTI format PET and magnetic resonance imaging (MRI) scans. It automates key post-processing tasks, including:
- Automatic co-registration and fusion of PET and MRI brain scans.
- Anatomic segmentation of brain regions using a convolutional neural network (CNN) algorithm trained on 3D MR images.
- Calculation of the standard uptake value ratio (SUVR) within designated target regions of interest compared to reference regions.
- Support for multiple beta-amyloid PET tracers and worklist options to streamline image analysis.
By automating image alignment and quantitative calculations, Veuron-Brain-pAb3 provides clinicians with objective, visualized data on amyloid protein concentrations to assist in diagnostic decision-making.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Processes PET and MRI brain images
- Detects and quantifies amyloid protein concentration
- Aids in diagnosing dementia
- Automates image registration and fusion
- Calculates Standard Uptake Value Ratios (SUVR)
- Visualizes and analyzes brain pathologies
- Enhances diagnostic accuracy
- Improves workflow efficiency
- Supports multiple PET tracers (e.g., Amyloid, Tau, FDG, FP-CIT)
- 105 brain regions segmentation
Use Cases
- Early diagnosis of Alzheimer's disease
- Assessment and quantification of amyloid pathologies in the brain
- Supporting clinical decision-making for dementia
- Research and clinical trials for neurodegenerative diseases
What Physicians Need to Know
Utilize Veuron-Brain-pAb3 for objective, quantitative assessment of amyloid burden in PET and MRI scans to support the diagnosis and monitoring of dementia, especially Alzheimer's disease. Integrate its automated image registration and SUVR calculation into your workflow to enhance diagnostic accuracy and streamline image interpretation. Remember that this tool is specifically for amyloid quantification and dementia diagnosis, and other Heuron solutions address stroke and other neurological conditions.
Veuron-Brain-pAb3 is deployed via medical imaging workplaces and is organized as a series of workflows specific to use with radiotracer and disease combinations. It is designed to register, fuse, display, and analyze medical images from multiple modalities, including MRI and PET.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated Veuron-Brain-pAb3 obtained 510(k) Clearance from the U.S. FDA on October 13, 2023. This clearance is for its function in the registration, fusion, display, and analysis of medical images from multiple modalities, including MRI and PET, specifically to aid clinicians in the assessment and quantification of pathologies from PET amyloid scans of the human brain. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Nuclear Medicine, Radiology |
What the Web Says
Veuron-Brain-pAb3 is an AI-powered software developed by Heuron Co., Ltd. for the analysis of medical images, specifically MRI and PET scans of the brain. It is designed to aid clinicians in the assessment and quantification of pathologies related to PET Amyloid scans, primarily for dementia diagnosis. The software calculates the Standardized Uptake Value Ratio (SUVR) within target regions of interest to visualize and quantify amyloid protein concentration. It received FDA 510(k) clearance in October 2023.
Overall: MixedStrengths
- Aids in faster and more accurate dementia diagnosis through AI-powered brain imaging analysis.
- Provides quantitative analysis of PET amyloid scans by calculating SUVR.
- Enables visualization of amyloid protein concentration in the brain.
- Supports clinicians in assessing and quantifying pathologies from PET Amyloid scans.
- FDA 510(k) cleared in October 2023.
- Utilizes multiple modalities including MRI and PET for comprehensive image analysis.
Limitations
- No readily available detailed reviews or opinions from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were found in the search results.
- No information on pricing or deployment was publicly available.
- No clinical testing was conducted for the Veuron-Brain-pAb3, with safety and effectiveness based on its predicate device.
Based on reviews from: FDA.report, accessdata.fda.gov, Physician Ai Tools, Innolitics, Heuron - ud734ub7f0, GlobalData, Radiology AI Tools Directory, HealthAidb u2014 Software
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Veuron-Brain-pAb3
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Veuron-Brain-pAb3.
Frequently Asked Questions
Investors who backed Veuron-Brain-pAb3
Funded through the company that built this tool.
